Finance

Beta
Lists
CNMD:NYSE
Conmed Corp
$35.95
+4.02%
(+1.39) 1D
$35.95
-0.00% (-0.00060)
After hours
Closed: Jun 26, 4:00:03 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CNMD...
Open
$34.81
High
$35.98
Low
$34.81
Mkt. cap
1.08B
Avg. vol.
538.94K
Volume
843.84K
P/E ratio
20.30
52-wk high
$56.64
52-wk low
$31.44
EPS
$1.77
Beta
0.92
Shares outstanding
30.11M
No. of employees
4K
Open
$34.81
High
$35.98
Low
$34.81
Mkt. cap
1.08B
Avg. vol.
538.94K
Volume
843.84K
P/E ratio
20.30
52-wk high
$56.64
52-wk low
$31.44
EPS
$1.77
Beta
0.92
Shares outstanding
30.11M
No. of employees
4K
News stories
From sources across the web
About Conmed Corp
CEOCurt R. Hartman
Employees3.9K
Founded1970
HeadquartersLargo, Florida, United States
SectorMedical device
Websiteconmed.com
Analyst ratings
Based on 4 analysts giving stock ratings to CNMD in the past 3 months
Hold
Buy
0
Hold
4
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for CNMD in the last 3 months.
Highest
Current $35.95
$40.00 (+11.27%)
Average
$38.74 (+7.76%)
Lowest
$35.96 (+0.03%)
Analyst
Recommendation
Action
Price target
Projected
Date
Travis Steed
Bank of America Securities
Hold
Maintained
$40.00
+11.3%
05/18/2026
Robbie Marcus
J.P. Morgan
Hold
Maintained
$40.00
+11.3%
04/30/2026
Matthew O'Brien
Piper Sandler
Hold
Reiterated
$39.00
+8.5%
04/30/2026
Michael Matson
Needham
Hold
Maintained
$35.96
+0%
04/30/2026
Larry Biegelsen
Wells Fargo
Hold
Maintained
$42.00
+16.8%
03/17/2026
Last report
Apr 29, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$0.89 / $0.82
+8.79%beat
Revenue / Est. (USD)
317.05M / 310.61M
+2.07%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
342.34M
337.93M
373.20M
317.05M
Cost of goods sold
148.92M
148.41M
196.81M
133.60M
Cost of revenue
148.92M
148.41M
196.81M
133.60M
Research and development expenses
14.14M
13.90M
14.90M
16.33M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
137.82M
139.00M
134.42M
133.48M
Operating expense
151.96M
152.90M
149.31M
149.81M
Total operating expenses
300.88M
301.31M
346.13M
283.41M
Operating income
41.46M
36.62M
27.07M
33.64M
Other non operating income
-418.00K
-
-363.00K
-
EBT including unusual items
29.92M
4.27M
29.25M
18.36M
EBT excluding unusual items
33.22M
29.01M
19.34M
26.58M
Income tax expense
8.50M
1.41M
12.51M
4.53M
Effective tax rate
28.40%
33.09%
42.78%
24.66%
Other operating expenses
-
-
-
-
Net income
21.42M
2.86M
16.74M
13.83M
Net profit margin
6.26%
0.85%
4.49%
4.36%
Earnings per share
1.15
1.08
1.43
0.89
Interest and investment income
-
-
-
-
Interest expense
-7.82M
-7.61M
-7.37M
-7.06M
Net interest expenses
-7.82M
-7.61M
-7.37M
-7.06M
Depreciation and amortization charges
-
-
-
-
EBITDA
60.03M
55.23M
44.72M
52.47M
Gain or loss from assets sale
-
-
-
-3.92M
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of CNMD
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer